Your browser is no longer supported. Please, upgrade your browser.
Settings
SPPI Spectrum Pharmaceuticals, Inc. daily Stock Chart
SPPI [NASD]
Spectrum Pharmaceuticals, Inc.
Index- P/E- EPS (ttm)-0.78 Insider Own0.80% Shs Outstand80.55M Perf Week-6.39%
Market Cap330.25M Forward P/E- EPS next Y-0.95 Insider Trans0.00% Shs Float72.50M Perf Month14.53%
Income-55.20M PEG- EPS next Q-0.29 Inst Own72.30% Short Float11.97% Perf Quarter-22.50%
Sales161.50M P/S2.04 EPS this Y-10.80% Inst Trans4.21% Short Ratio10.30 Perf Half Y-44.14%
Book/sh3.16 P/B1.30 EPS next Y8.70% ROA-13.00% Target Price9.00 Perf Year-29.31%
Cash/sh2.13 P/C1.92 EPS next 5Y- ROE-24.30% 52W Range3.21 - 7.74 Perf YTD-32.01%
Dividend- P/FCF- EPS past 5Y3.80% ROI-13.20% 52W High-48.06% Beta1.21
Dividend %- Quick Ratio3.60 Sales past 5Y17.00% Gross Margin81.00% 52W Low25.23% ATR0.24
Employees212 Current Ratio3.70 Sales Q/Q16.80% Oper. Margin-29.30% RSI (14)46.07 Volatility5.20% 6.47%
OptionableYes Debt/Eq0.42 EPS Q/Q22.60% Profit Margin-34.20% Rel Volume0.41 Prev Close4.10
ShortableYes LT Debt/Eq0.42 EarningsNov 14 BMO Payout- Avg Volume842.43K Price4.02
Recom2.00 SMA20-2.55% SMA50-3.95% SMA200-30.93% Volume273,161 Change-1.95%
Nov-05-15Reiterated RBC Capital Mkts Outperform $13 → $12
Aug-07-15Reiterated RBC Capital Mkts Outperform $12 → $13
Apr-02-15Initiated FBR Capital Outperform $9
Feb-23-15Downgrade ROTH Capital Buy → Neutral $15 → $7
Jul-15-14Upgrade R. F. Lafferty Sell → Neutral $7.50
Oct-07-13Initiated HC Wainwright Buy $15
May-29-13Initiated Burrill Institutional Research Mkt Outperform $12
Mar-13-13Reiterated RBC Capital Mkts Outperform $19 → $16
Mar-13-13Downgrade WallachBeth Buy → Sell $20 → $5.50
May-02-11Reiterated MLV Capital Buy $12.50 → $20.50
Mar-25-11Initiated RBC Capital Mkts Outperform $12
Dec-07-10Reiterated Morgan Joseph Buy $8 → $10
Jan-12-10Upgrade Morgan Joseph Hold → Buy $8
Oct-14-09Reiterated Rodman & Renshaw Mkt Outperform $10 → $8
Sep-08-09Downgrade Morgan Joseph Buy → Hold
Sep-09-08Initiated Morgan Joseph Buy $5
Apr-23-08Downgrade Oppenheimer Outperform → Perform
Mar-18-08Downgrade Brean Murray Buy → Hold
Nov-01-07Reiterated Friedman Billings Mkt Perform $5.50 → $4
Oct-31-07Reiterated Rodman & Renshaw Mkt Outperform $8 → $6
Dec-02-16 07:00AM  Spectrum Pharmaceuticals Highlights Four Abstracts at the 58th Annual Meeting of the American Society of Hematology (ASH) in San Diego, California, December 3-6, 2016 Business Wire
Nov-29-16 03:15PM  SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Spectrum Pharmaceuticals, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors Accesswire
07:24AM  Spectrum Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : SPPI-US : November 29, 2016
Nov-28-16 12:30PM  ETFs with exposure to Spectrum Pharmaceuticals, Inc. : November 28, 2016 -5.31%
Nov-23-16 01:04PM  SPECTRUM PHARMACEUTICALS INC Financials
06:31AM  Biotech Stock Roundup: Acorda Stops Ampyra PSWD Development, CRL for Spectrum's Qapzola
Nov-22-16 11:14AM  Spectrum Pharmaceuticals, Inc. :SPPI-US: Earnings Analysis: Q3, 2016 By the Numbers : November 22, 2016
Nov-21-16 08:55AM  Spectrum Bladder Cancer Drug Nixed by FDA (SPPI) at Investopedia +5.85%
07:24AM  Spectrum (SPPI) Gets CRL for Bladder Cancer Drug in U.S.
Nov-18-16 12:06PM  3-DAY DEADLINE: Khang & Khang LLP Announces Securities Class Action Lawsuit against Spectrum Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm Accesswire
11:04AM  SPPI UPCOMING DEADLINE: The Law Offices of Vincent Wong Reminds Shareholders of a Class Action Involving Spectrum Pharmaceuticals, Inc. and a Lead Plaintiff Deadline of November 21, 2016 PR Newswire
06:22AM  Spectrum Pharma says U.S. FDA rejects its bladder cancer drug Reuters
06:01AM  SPECTRUM PHARMACEUTICALS INC Files SEC form 8-K, Other Events
Nov-17-16 11:47AM  UPCOMING DEADLINE: Lundin Law PC Announces Securities Class Action Lawsuit against Spectrum Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm Accesswire
10:30AM  Deadline Alert: Law Offices of Howard G. Smith Reminds Investors of the Upcoming November 21st Deadline in the Class Action Lawsuit Against Spectrum Pharmaceuticals, Inc. Business Wire
07:00AM  Spectrum Pharmaceuticals Announces Poziotinib Data Presentation at the 17th IASLC World Conference on Lung Cancer in Vienna, Austria, December 4-7, 2016 Business Wire
Nov-16-16 11:39AM  APPROACHING DEADLINE: Khang & Khang LLP Announces Securities Class Action Lawsuit against Spectrum Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm Accesswire
10:10AM  DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Spectrum Pharmaceuticals Inc. (SPPI) & Lead Plaintiff Deadline: November 21, 2016 GlobeNewswire
Nov-15-16 02:26PM  ETFs with exposure to Spectrum Pharmaceuticals, Inc. : November 15, 2016 -8.14%
09:13AM  Spectrum (SPPI) Reports Narrower-than-Expected Q3 Loss
Nov-14-16 04:23PM  IMPORTANT INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Spectrum Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm Accesswire +6.44%
02:22PM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Spectrum Pharmaceuticals, Inc. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of November 21, 2016 Business Wire
11:50AM  INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Spectrum Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm Business Wire
10:10AM  Final Opportunity For Spectrum Pharmaceuticals Shareholders To Apply For Lead Plaintiff Status In Pending Securities Fraud Lawsuit Accesswire
07:54AM  Spectrum Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : SPPI-US : November 14, 2016
07:52AM  SPECTRUM PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements
07:25AM  Spectrum Pharma reports 3Q loss
07:00AM  Spectrum Pharmaceuticals Provides Third Quarter Financial Update Business Wire
Nov-09-16 05:24PM  IMPORTANT SHAREHOLDER ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Spectrum Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm Business Wire +15.79%
02:40PM  SPPI SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notifies Shareholders of a Class Action Involving Spectrum Pharmaceuticals, Inc. and a Lead Plaintiff Deadline of November 21, 2016 Business Wire
02:18PM  Upcoming Deadline For Spectrum Pharmaceuticals Shareholders To Apply For Lead Plaintiff Status In Pending Securities Fraud Lawsuit Accesswire
01:52PM  SPPI LOSS ALERT: Rosen Law Firm Reminds Spectrum Pharmaceuticals, Inc. Investors of Important November 21 Deadline in Class Action Filed by Firm- SPPI GlobeNewswire
Nov-08-16 11:07AM  SHAREHOLDER ALERT: Goldberg Law PC Announces Securities Class Action Lawsuit against Spectrum Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm Business Wire
10:25AM  DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Spectrum Pharmaceuticals Inc. (SPPI) & Lead Plaintiff Deadline: November 21, 2016 Accesswire
09:30AM  SPECTRUM PHARMACEUTICALS INVESTOR REMINDER: Hagens Berman Reminds Spectrum Pharmaceuticals Inc. Investors of the Lead Plaintiff Deadline in Securities Class Action GlobeNewswire
Nov-04-16 12:46PM  SHAREHOLDER ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Spectrum Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm Business Wire +9.32%
11:40AM  SPPI INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Shareholders of a Class Action Involving Spectrum Pharmaceuticals, Inc. and a Lead Plaintiff Deadline of November 21, 2016 GlobeNewswire
Nov-03-16 04:09PM  SPECTRUM PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements -7.74%
04:05PM  Spectrum Pharmaceuticals Provides Third Quarter Financial and Pipeline Update Business Wire
02:16PM  IMPORTANT INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Spectrum Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm Business Wire
10:19AM  SHAREHOLDER ALERT- Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Spectrum Pharmaceuticals Inc. (SPPI) & Lead Plaintiff Deadline: November 21, 2016 Accesswire
07:07AM  Q3 2016 Spectrum Pharmaceuticals Inc Earnings Release - After Market Close
Oct-31-16 05:53PM  INVESTOR ALERT: Goldberg Law PC Announces Securities Class Action Lawsuit against Spectrum Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm Business Wire
04:51PM  GPM Reminds Investors of the November 21st Deadline in the Class Action Lawsuit Against Spectrum Pharmaceuticals, Inc. and Encourages Investors to Contact the Firm Business Wire
11:10AM  INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Spectrum Pharmaceuticals, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of November 21, 2016 SPPI GlobeNewswire
Oct-27-16 10:23AM  SHAREHOLDER ALERT- Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Spectrum Pharmaceuticals Inc. (SPPI) and Lead Plaintiff Deadline: November 21, 2016 Accesswire
07:00AM  Spectrum Pharmaceuticals Announces Third Quarter 2016 Financial Results Teleconference and Webcast Business Wire
Oct-26-16 02:53PM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Spectrum Pharmaceuticals, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of November 21, 2016 - SPPI Accesswire
01:01PM  EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Spectrum Pharmaceuticals, Inc. - SPPI GlobeNewswire
Oct-20-16 10:17AM  Cohen Milstein Sellers & Toll PLLC Announces Investigation of Spectrum Pharmaceuticals, Inc. Business Wire
Oct-19-16 03:38PM  Glancy Prongay & Murray Announces the Filing of a Securities Class Action on Behalf of Spectrum Pharmaceuticals, Inc. Investors and Encourages Investors to Contact the Firm Business Wire
12:53PM  INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Spectrum Pharmaceuticals, Inc. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of November 21, 2016 -- SPPI Marketwired
10:18AM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Spectrum Pharmaceuticals Inc. (SPPI) and Lead Plaintiff Deadline: November 21, 2016 Accesswire
Oct-18-16 07:10AM  SPECTRUM PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
07:00AM  Spectrum Pharmaceuticals Announces Appointment of Luigi Lenaz, M.D., as Lead Director Business Wire
Oct-14-16 10:10AM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Spectrum Pharmaceuticals Inc. (SPPI) and Lead Plaintiff Deadline: November 21, 2016 GlobeNewswire -6.84%
Oct-11-16 12:36PM  SPPI LOSS NOTICE: Rosen Law Firm Reminds Spectrum Pharmaceuticals, Inc. Investors of Important Deadline in Class Action Filed by Firm - SPPI Business Wire
10:44AM  SPPI SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notifies Shareholders of a Class Action Involving Spectrum Pharmaceuticals, Inc. and a Lead Plaintiff Deadline of November 21, 2016 GlobeNewswire
Oct-10-16 08:32PM  Lifshitz & Miller Law Firm Announces Investigation of Inteliquent, Inc., Isle of Capri Casinos, Inc., Janus Capital Group, Inc., MGT Capital Investments, Inc., MoneyGram International Inc., Neos Therapeutics, Inc., Spectrum Pharmaceuticals, PR Newswire
10:32AM  Johnson & Weaver, LLP Initiates Investigations of Puma Biotechnology, Inc., Virtus Investment Partners, Inc., AAC Holdings, Inc. and Spectrum Pharmaceuticals, Inc.; Encourages Long-Term Investors to Contact the Firm Regarding Their Legal Ri PR Newswire
Oct-07-16 02:29PM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Spectrum Pharmaceuticals, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of November 21, 2016 SPPI GlobeNewswire
10:19AM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Spectrum Pharmaceuticals Inc. (SPPI) and Lead Plaintiff Deadline: November 21, 2016 Accesswire
Oct-06-16 02:15PM  SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Spectrum Pharmaceuticals, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors PR Newswire
Oct-05-16 09:30AM  SPECTRUM PHARMACEUTICALS INVESTOR ALERT: Hagens Berman Alerts Spectrum Pharmaceuticals Inc. Investors to Expanded Class Period and Lead Plaintiff Deadline GlobeNewswire
Oct-04-16 10:22AM  ETFs with exposure to Spectrum Pharmaceuticals, Inc. : October 4, 2016
Oct-03-16 01:42PM  The Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Spectrum Pharmaceuticals, Inc. Investors and Encourages Investors to Contact the Firm Business Wire
09:44AM  Spectrum Pharmaceuticals Sued for Securities Fraud With Expanded Class Period By Block & Leviton LLP After Company Revealed It Concealed Discouraging Advice From The FDA PR Newswire
Sep-30-16 12:55PM  SECURITIES NOTICE: Rosen Law Firm Reminds Spectrum Pharmaceuticals, Inc. Investors of Important Deadline in Class Action Filed by Firm- SPPI PR Newswire
Sep-28-16 06:18PM  IMPORTANT SPECTRUM PHARMACEUTICALS, INC. SHAREHOLDER ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed on behalf of shareholders of Spectrum Pharmaceuticals, Inc. Accesswire
10:10AM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Spectrum Pharmaceuticals Inc. (SPPI) and Lead Plaintiff Deadline: November 21, 2016 GlobeNewswire
07:37AM  Inside The FDA: Spectrum Pharmaceuticals, Inc. (SPPI) and its Bladder Cancer Treatment, Apaziquone at Insider Monkey
Sep-27-16 02:13PM  Robbins Arroyo LLP: Spectrum Pharmaceuticals, Inc. (SPPI) Misled Shareholders According to a Recently Filed Class Action Business Wire
Sep-23-16 11:23AM  INVESTOR ALERT: Investigation of Spectrum Pharmaceuticals, Inc. Announced by Law Offices of Howard G. Smith Business Wire
10:49AM  SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Spectrum Pharmaceuticals, Inc. - SPPI GlobeNewswire
09:30AM  SPECTRUM PHARMACEUTICALS INVESTOR ALERT: Hagens Berman Alerts Spectrum Pharmaceuticals Inc. Investors to Class Action and Lead Plaintiff Deadline GlobeNewswire
Sep-22-16 12:50PM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Spectrum Pharmaceuticals Inc. (SPPI) and Lead Plaintiff Deadline: November 21, 2016 PR Newswire +7.61%
Sep-21-16 04:53PM  SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Spectrum Pharmaceuticals, Inc. To Contact The Firm Business Wire
02:24PM  Glancy Prongay & Murray LLP Commences Investigation on Behalf of Spectrum Pharmaceuticals, Inc. Investors Business Wire
12:35PM  EQUITY ALERT: Rosen Law Firm Files Securities Class Action Against Spectrum Pharmaceuticals, Inc. - SPPI Business Wire
09:30AM  SPECTRUM PHARMACEUTICALS INVESTOR ALERT: Hagens Berman is Investigating Possible Securities Law Violations by Spectrum Pharmaceuticals Inc. and Officers GlobeNewswire
07:08AM  Hynes Keller & Hernandez, LLC Announces Investigation of Spectrum Pharmaceuticals, Inc. (SPPI) PR Newswire
Sep-20-16 04:03PM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces the Commencement of an Investigation Involving Possible Securities Fraud Violations by Spectrum Pharmaceuticals, Inc. Business Wire
10:50AM  SHAREHOLDER ALERT: Goldberg Law PC Announces an Investigation of Spectrum Pharmaceuticals, Inc. Business Wire
09:31AM  SPECTRUM PHARMACEUTICALS NOTIFICATION: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Spectrum Pharmaceuticals, Inc. To Contact The Firm PR Newswire
Sep-19-16 07:19PM  IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces an Investigation of Spectrum Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm Business Wire
06:10PM  EQUITY ALERT: Rosen Law Firm Announces Investigation of Securities Claims Against Spectrum Pharmaceuticals, Inc. Business Wire
11:33AM  IMPORTANT INVESTOR ALERT: Lundin Law PC Announces an Investigation of Spectrum Pharmaceuticals, Inc. and Advises Investors with Losses to Contact the Firm Business Wire
10:15AM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Spectrum Pharmaceuticals Inc. (SPPI) PR Newswire
Sep-16-16 07:07PM  INVESTOR ALERT: Goldberg Law PC Announces an Investigation of Spectrum Pharmaceuticals, Inc. Business Wire
01:20PM  Block & Leviton LLP Investigates Spectrum Pharmaceuticals After Revelation That Company Concealed Discouraging Advice From FDA PR Newswire
11:47AM  Spectrum Pharma, FDA and the Buried Truth About a Bladder Cancer Drug Meeting
09:30AM  Two Biotechs With Bad News This Week: What Happens Now? at Insider Monkey
Sep-15-16 05:29PM  Spectrum (SPPI) Down, Qapzola Fails to Impress FDA Panel
08:56AM  FDA AdCom Votes on Pfizer and Spectrum Drugs - What Next?
Sep-14-16 02:51PM  Spectrum bladder cancer drug not effective - U.S. FDA panel Reuters -8.20%
02:21PM  SPECTRUM PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
02:15PM  Spectrum Pharmaceuticals (SPPI) Stock Slumps on FDA Ruling
01:25PM  Spectrum Pharmaceuticals' stock drops after cancer treatment voted down by FDA committee at MarketWatch
01:06PM  FDA Advisory Committee Votes that Qapzola (apaziquone) Has Not Shown Substantial Evidence of a Treatment Effect Over Placebo Business Wire
08:47AM  Biotech Stock Roundup: Horizon-Raptor Acquisition Deal, Geron Down on Pipeline News
Spectrum Pharmaceuticals, Inc., a biotechnology company, develops and commercializes oncology and hematology drug products. The company markets six drug products, including FUSILEV for patients with metastatic colorectal cancer, rescue after high-dose methotrexate therapy in osteosarcoma, and to diminish the toxicity and counteract the effects of impaired methotrexate elimination and of inadvertent overdosage of folic acid antagonists; FOLOTYN, a folate analogue metabolic inhibitor to treat patients with relapsed or refractory PTCL; ZEVALIN injection for patients with follicular non-Hodgkin's lymphoma; MARQIBO, a sphingomyelin/cholesterol liposome-encapsulated formulation of the anticancer drug vincristine for adult patients with Philadelphia chromosome-negative acute lymphoblastic leukemia; BELEODAQ injection for patients with relapsed or refractory PTCL; and EVOMELA for use as a conditioning treatment prior to autologous stem cell transplant in multiple myeloma patients. It is also developing POZIOTINIB for treating breast, gastric, colorectal, and lung cancers; EOQUIN for non-muscle invasive bladder cancer; and SPI-2012 for chemotherapy-induced neutropenia in patients with breast cancer. The company sells its drugs through a direct sales force in the United States; and through distributors in Europe. It has licensing and development agreement with Cell Therapeutics, Inc.; license agreement with Merck & Cie AG, Sloan-Kettering Institute, and Cydex Pharmaceuticals, Inc.; development and commercialization collaboration agreement with Allergan, Inc.; collaboration agreement with Nippon Kayaku Co., Ltd.; licensing and collaboration agreement with TopoTarget A/S; and co-development and commercialization agreement with Hanmi Pharmaceutical Company. The company was formerly known as NeoTherapeutics, Inc. and changed its name to Spectrum Pharmaceuticals, Inc. in December 2002. Spectrum Pharmaceuticals, Inc. was founded in 1987 and is headquartered in Henderson, Nevada.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
SHROTRIYA RAJESH C MDChairman & CEODec 22Option Exercise4.23129,248546,719101,426Dec 23 04:03 PM